GlassScriptPhysician profile
Walter Z Falconer
NPI 1841393188
$12,931.62
in general payments reported to CMS, 2019-2025
45 companies · $4,637 in 2025
The $4,637 reported for 2025 was more than what 90% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,760 · 2020: $596 · 2021: $1,194 · 2022: $1,739 · 2023: $944 · 2024: $1,061 · 2025: $4,637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,879 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Travel and Lodging: $763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,879.06 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Travel and Lodging | $763.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $3,078.25 | 2019-2025 | Titan |
| Avyxa Pharma, LLC | $3,069.26 | 2025 | |
| Pfizer INC. | $687.11 | 2019-2025 | |
| Astellas Pharma US INC | $671.20 | 2019-2025 | Xtandi |
| Sumitomo Pharma America, INC. | $555.00 | 2023-2025 | Orgovyx, Gemtesa |
| Medtronic, INC. | $453.36 | 2022-2025 | Interstim |
| Bayer Healthcare Pharmaceuticals INC. | $417.71 | 2019-2025 | |
| Myovant Sciences INC. | $413.28 | 2021-2022 | |
| Janssen Biotech, INC. | $365.28 | 2019-2025 | Erleada |
| Boston Scientific Corporation | $321.30 | 2019-2025 | Spaceoar Vue System - 10ml, Spaceoar System, Axonics |
| Myriad Genetic Laboratories, INC. | $289.32 | 2021-2025 | Prolaris |
| Endo Pharmaceuticals INC. | $272.03 | 2019-2022 | |
| Urovant Sciences INC | $226.05 | 2021-2022 | |
| Blue Earth Diagnostics | $217.29 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $198.43 | 2019-2025 | Provenge |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Srs Medical Systems, INC. | $154.16 | 2021 | |
| Antares Pharma, INC. | $142.46 | 2020-2024 | Xyosted, Nocdurna, Tlando |
| Ferring Pharmaceuticals INC. | $136.54 | 2019-2025 | Adstiladrin |
| Tempus Ai, INC | $120.24 | 2024-2025 | Xt Cdx |
| Tolmar, INC. | $94.65 | 2025 | Jatenzo, Eligard |
| Merck Sharp & Dohme LLC | $92.80 | 2020-2024 | Lynparza, Keytruda |
| Foundation Medicine, INC. | $88.48 | 2022-2023 | |
| Endo USA, INC. | $75.42 | 2025 | Xiaflex, Aveed |
| Amgen INC. | $70.80 | 2019-2020 | |
| Abc Home Medical Supply, INC. | $63.69 | 2024 | |
| Neotract INC. | $61.43 | 2020 | |
| Laborie Medical Technologies Corp. | $55.86 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Acerus Pharmaceuticals Corporation | $53.83 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $50.84 | 2020-2023 | Lynparza |
| Verity Pharmaceuticals INC. | $42.76 | 2022-2025 | Tlando |
| Angiodynamics, INC. | $42.56 | 2022 | |
| Allergan, INC. | $41.60 | 2019-2021 | |
| Urogen Pharma, INC. | $38.47 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $36.69 | 2025 | Magic3 Go Intermittent Urinary Catheter |
| Axonics, INC. | $35.71 | 2022 | |
| Teleflex LLC | $33.28 | 2021-2022 | |
| Trevena, INC. | $28.81 | 2021 | |
| Abbvie INC. | $23.29 | 2023 | |
| Novartis Pharmaceuticals Corporation | $22.33 | 2025 | |
| Clarus Therapeutics INC. | $16.38 | 2021 | |
| Halozyme INC | $16.12 | 2023 | |
| Sun Pharmaceutical Industries INC. | $16.01 | 2019 | |
| Baxter Healthcare | $15.69 | 2019 | |
| Travere Therapeutics, INC. | $13.93 | 2019-2021 | |
| Dentsply Ih Ab | $11.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Falconer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.